Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery

被引:97
作者
Hohman, Moses [1 ]
Gregory, Kellan [1 ]
Chibale, Kelly [2 ,3 ]
Smith, Peter J. [4 ]
Ekins, Sean [5 ,6 ,7 ]
Bunin, Barry [1 ]
机构
[1] Collaborat Drug Discovery Inc, Burlingame, CA 94403 USA
[2] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7701 Rondebosch, South Africa
[3] Univ Cape Town, Dept Chem, ZA-7701 Rondebosch, South Africa
[4] Univ Cape Town, Div Pharmacol, Dept Med, Groote Schuur Hosp,Sch Med,OMB, ZA-7925 Observatory, South Africa
[5] Collaborat Chem, Jenkintown, PA 19046 USA
[6] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA
[7] Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA
关键词
OLD DRUGS; PLASMODIUM-FALCIPARUM; IN-VITRO; COLLABORATION; RECEPTOROME; DATABASES; INTERNET; DISEASES; PROTEIN; DESIGN;
D O I
10.1016/j.drudis.2008.11.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A convergence of different commercial and publicly accessible chemical informatics, databases and social networking tools is positioned to change the way that research collaborations are initiated, maintained and expanded, particularly in the realm of neglected diseases. A community-based platform that combines traditional drug discovery informatics with Web2.0 features in secure groups is believed to be the key to facilitating richer, instantaneous collaborations involving sensitive drug discovery data and intellectual property. Heterogeneous chemical and biological data from low-throughput or high-throughput experiments are archived, mined and then selectively shared either just securely between specifically designated colleagues or openly on the Internet in standardized formats. We will illustrate several case studies for anti-malarial research enabled by this platform, which we suggest could be easily expanded more broadly for pharmaceutical research in general.
引用
收藏
页码:261 / 270
页数:10
相关论文
共 41 条
[1]  
[Anonymous], 2006, DEV NEW TECHNOLOGIES
[2]   Network biology:: Understanding the cell's functional organization [J].
Barabási, AL ;
Oltvai, ZN .
NATURE REVIEWS GENETICS, 2004, 5 (02) :101-U15
[3]  
BUNIN BA, 2007, CHEMINFORMATICS THEO
[4]   Structural e-bioinformatics and drug design [J].
Carpy, AJM ;
Marchand-Geneste, N .
SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2006, 17 (01) :1-10
[5]   Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives [J].
Chiyanzu, I ;
Clarkson, C ;
Smith, PJ ;
Lehman, J ;
Gut, J ;
Rosenthal, PJ ;
Chibale, K .
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (09) :3249-3261
[6]   New uses for old drugs [J].
Chong, Curtis R. ;
Sullivan, David J., Jr. .
NATURE, 2007, 448 (7154) :645-646
[7]   A clinical drug library screen identifies astemizole as an antimalarial agent [J].
Chong, Curtis R. ;
Chen, Xiaochun ;
Shi, Lirong ;
O Liu, Jun ;
Sullivan, David J., Jr. .
NATURE CHEMICAL BIOLOGY, 2006, 2 (08) :415-416
[8]   Exploiting a basic chemosensitizing pharmacophore hypothesis. Part 1: Synthesis and biological evaluation of novel arylbromide and bicyclic chemosensitizers against drug-resistant malaria parasites [J].
Chouteau, F ;
Ramanitrahasimbola, D ;
Rasoanaivo, P ;
Chibale, K .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (12) :3024-3028
[9]   Novel trends in orphan market drug discovery: Amyotrophic lateral sclerosis as a case study [J].
Clark, JE ;
Brennan, A ;
Ramesh, TM ;
Heywood, JA .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2002, 7 :C83-C96
[10]   In silico pharmacology for drug discovery:: methods for virtual ligand screening and profiling [J].
Ekins, S. ;
Mestres, J. ;
Testa, B. .
BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (01) :9-20